TY  - JOUR
PY  - 2021//
TI  - An emotion regulation tablet app for middle-aged and older adults at high suicide risk: feasibility, acceptability, and two case studies
JO  - American journal of geriatric psychiatry
A1  - Kiosses, Dimitris N.
A1  - Monkovic, Jody
A1  - Stern, Amy
A1  - Czaja, Sara J.
A1  - Alexopoulos, George
A1  - Arslanoglou, Elizabeth
A1  - Ebo, Theresa
A1  - Pantelides, Joanna
A1  - Yu, Huaian
A1  - Dunefsky, Jacob
A1  - Smeragliuolo, Anna
A1  - Putrino, David
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - OBJECTIVE  The unique features of technological applications may improve the treatment of peopleat risk of suicide. In this article, we present feasibility and acceptability data as well as two case studies demonstrating the use of WellPATH, a tablet app that aims to help suicidal patients during emotionally-charged situations outside of therapy sessions. The WellPATH app was part of a 12-week psychotherapy intervention (CRISP- Cognitive Reappraisal Intervention for Suicide Prevention) for middle-aged and older adults after their discharge from a suicide-related hospitalization.   Design  The use of WellPATH includes three stages: preparation and practice, incorporation, and actual use.   Measurements  Feasibility was measured by the overall use of WellPATH during twelve weeks, and acceptability was measured with the three items of the Client Satisfaction Questionnaire.   Results  Twelve study participants were administered WellPATH as part of CRISP. The results provide preliminary evidence of feasibility and acceptability of WellPATH. Study participants and therapists reported high satisfaction with WellPATH and provided feedback for further research and development. The patients in the case studies reported a reduction in negative emotions and an increase in emotion regulation (i.e., cognitive reappraisal ability) after using techniques on the WellPATH app.   Conclusions  Our preliminary findings suggest that use of technology applications such as the WellPATH app is feasible and accepted among middle-aged and older adults at high suicide risk. Further research with an adequately powered sample is needed to further evaluate WellPATH's feasibility and accessibility, and test its efficacy with this high-risk population.<p />  <p>Language: en</p>
LA  - en
SN  - 1064-7481
UR  - http://dx.doi.org/10.1016/j.jagp.2021.08.015
ID  - ref1
ER  -